Broome Oncology

Latest Cancer News

The US Food and Drug Administration has approved Besponsa for the Treatment of Refractory B-cell Precursor Acute Lymphoblastic Leukemia (08-22-2017)
Besponsa (Inotuzumab ozogamicin) is a targeted therapy designed to bind to B-cell acute lymphoblastic leukemia (ALL) cancer cells that express the CD22 antigen. Acute lymphoblastic leukemia comprises approximately... Continue Reading

U.S. FDA Removes Clinical Hold on CEL-SCI’s Phase 3 Head & Neck Cancer Trial (08-21-2017)
CEL-SCI Corporation today announced it has received a letter from the U.S. Food and Drug Administration (FDA) stating that the clinical hold that had been imposed on the Company’s Phase 3 cancer study... Continue Reading

Cervical Cancer Survivors Frequently Suffer From Long-Term Side Effects of Treatment (08-17-2017)
According to a new study around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia, fatigue or hot flushes.1 Cervical cancer affects more than 500,000... Continue Reading

More Cancer News

Locations

Binghamton
169 Riverside Drive
Binghamton, NY 13905
(607) 798-5307
Click here to visit the Lourdes website
Johnson City
30 Harrison Street
Johnson City, NY 13790
(607) 763-6850
Click here to visit the UHS website
Office Hours (both locations)
Monday – Thursday 8:00am – 4:30pm
Friday 8:00am- 12:00pm